Objectives: To determine the information needs and preferences of patients who had human papillomavirus–associated head and neck cancer (HNC) and who were aged 18–65 years in the post-treatment phase of recovery. Sample & Setting: 205 patients who completed treatment for HNC at two large cancer...

Background: With the advent of biosimilars into the U.S. healthcare market, knowledge deficits exist for nurses and patients regarding the regulatory approval process and key nursing considerations for each of these new medications. Objectives: This article provides essential clinical information...

Background: Biosimilars provide opportunities for improving healthcare access and outcomes and reducing overall healthcare costs for patients with cancer. Objectives: The purpose of this article is to explore the history of biosimilars, regulatory pathways, and barriers to biosimilar approval. This...

Background: The development of biosimilars is occurring more rapidly as patents on biologics expire. Oncology nurses will have an integral role in the new era of biosimilars regarding administration and education. Objectives: The purpose of this article is to review the role of the oncology nurse...